Complete Filing Data
Elicio Therapeutics, Inc. reported Stockholders Equity of $1.64 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Elicio Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue * | $2.3M | $27.5M | $193.0K | |||
| Net Income Loss | -$39.6M | -$51.9M | -$35.2M | -$28.2M | -$54.6M | -$80.1M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $48.0K | $22.0K | -$197.0K | $0.00 | $230.0K | -$333.0K |
| Research And Development Expense | $24.9M | $33.7M | $23.8M | $18.1M | $48.7M | $39.0M |
| Operating Income Loss | -$37.7M | -$45.0M | -$35.7M | -$23.7M | -$39.3M | -$55.3M |
| Nonoperating Income Expense | -$1.9M | -$6.9M | $550.0K | -$4.5M | -$15.3M | -$24.8M |
| General And Administrative Expense | $12.8M | $11.3M | $11.9M | $5.6M | $18.5M | $18.0M |
| Comprehensive Income Net Of Tax | -$39.5M | -$51.9M | -$35.4M | -$28.2M | -$54.3M | -$80.4M |
| Interest Income Expense Net | $805.0K | -$1.8M | -$8.8M | |||
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | $151.0K | -$99.0K | -$71.0K | |||
| Income Loss From Equity Method Investments | $151.0K | -$96.0K | -$71.0K | |||
| Cost Of Revenue | $0.00 | $433.0K | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $0.00 | $0.00 | $653.0K | $1.6M | $1.5M | $540.0K | $371.0K | $0.00 | $0.00 | $0.00 | ||||||||
| Net Income Loss | -$10.1M | -$10.6M | -$11.2M | -$18.8M | -$7.2M | -$11.8M | -$10.7M | -$7.6M | -$8.0M | -$7.2M | -$7.3M | -$7.1M | -$15.7M | -$17.1M | -$36.7M | -$17.7M | -$20.3M | -$13.2M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $39.0K | $74.0K | $31.0K | $36.0K | $32.0K | -$73.0K | -$23.0K | -$2.0K | $0.00 | $0.00 | $0.00 | -$96.0K | $146.0K | $68.0K | $46.0K | -$18.0K | -$196.0K | $149.0K |
| Research And Development Expense | $5.0M | $7.0M | $7.8M | $7.2M | $8.2M | $7.6M | $7.3M | $4.9M | $5.5M | $4.6M | $5.0M | $11.7M | $13.3M | $14.4M | $14.3M | $6.1M | $12.2M | $9.6M |
| Operating Income Loss | -$8.0M | -$10.1M | -$10.7M | -$10.3M | -$10.9M | -$10.2M | -$10.8M | -$7.8M | -$7.8M | -$5.8M | -$6.2M | -$14.5M | -$15.8M | -$18.2M | -$19.9M | -$11.6M | -$17.3M | -$12.6M |
| Nonoperating Income Expense | -$2.0M | -$470.0K | -$473.0K | -$8.5M | $3.7M | -$1.6M | $113.0K | $218.0K | -$224.0K | -$1.4M | -$1.1M | $245.0K | $54.0K | $1.2M | -$16.7M | -$6.1M | -$3.1M | -$653.0K |
| General And Administrative Expense | $3.0M | $3.1M | $3.0M | $3.1M | $2.7M | $2.7M | $3.5M | $2.8M | $2.3M | $1.2M | $1.2M | $4.5M | $3.9M | $4.3M | $6.0M | $6.0M | $5.4M | $3.5M |
| Comprehensive Income Net Of Tax | -$10.0M | -$10.5M | -$11.2M | -$18.8M | -$7.2M | -$11.9M | -$10.7M | -$7.6M | -$8.0M | -$7.2M | -$7.3M | -$14.3M | -$15.6M | -$17.0M | -$36.6M | -$17.7M | -$20.5M | -$13.1M |
| Interest Income Expense Net | $469.0K | $259.0K | $58.0K | $86.0K | $110.0K | $124.0K | -$2.2M | -$2.6M | -$487.0K | -$180.0K | ||||||||
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | $0.00 | $9.0K | $133.0K | $9.0K | $20.0K | -$35.0K | $55.0K | $0.00 | $28.0K | $28.0K | ||||||||
| Income Loss From Equity Method Investments | $0.00 | $9.0K | $67.0K | $28.0K | ||||||||||||||
| Cost Of Revenue | $0.00 | $0.00 | $0.00 | $348.0K | $333.0K | $383.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.6M | -$11.3M | $11.4M | -$102.1M | -$74.5M | -$90.4M | -$18.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.3M | $19.5M | $14.3M | $8.4M | $10.0M | $34.6M | $5.6M |
| Gains Losses On Extinguishment Of Debt | $0.00 | $605.0K | $2.0K | $905.0K | $0.00 | ||
| Cash And Cash Equivalents At Carrying Value | $18.6M | $17.6M | $12.9M | $6.2M | $88.8M | $34.6M | |
| Operating Lease Right Of Use Asset Amortization Expense | $924.0K | $857.0K | $788.0K | $667.0K | $710.0K | $530.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$225.0K | $5.2M | $5.9M | -$1.6M | $54.1M | $29.0M | |
| Retained Earnings Accumulated Deficit | -$233.7M | -$194.1M | -$142.2M | -$107.0M | -$215.1M | -$160.6M | |
| Property Plant And Equipment Net | $295.0K | $483.0K | $717.0K | $1.1M | $451.0K | $156.0K | |
| Prepaid Expense And Other Assets Current | $748.0K | $1.9M | $2.7M | $2.9M | $1.7M | $7.7M | |
| Operating Lease Right Of Use Asset | $4.8M | $5.7M | $6.6M | $7.4M | $4.0M | $4.1M | |
| Operating Lease Liability Noncurrent | $4.1M | $5.1M | $6.0M | $6.8M | $3.5M | $3.8M | |
| Operating Lease Liability Current | $1.0M | $901.0K | $910.0K | $692.0K | $894.0K | $611.0K | |
| Liabilities Current | $8.1M | $11.5M | $9.8M | $6.9M | $11.3M | $107.4M | |
| Liabilities And Stockholders Equity | $25.9M | $28.2M | $27.1M | $22.7M | $96.5M | $47.3M | |
| Liabilities | $24.2M | $39.5M | $15.8M | $13.7M | $15.0M | $137.8M | |
| Common Stock Value | $178.0K | $110.0K | $96.0K | $3.0K | $300.0K | $156.0K | |
| Assets Current | $19.3M | $20.7M | $16.3M | $10.7M | $91.2M | $42.3M | |
| Assets | $25.9M | $28.2M | $27.1M | $22.7M | $96.5M | $47.3M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$127.0K | -$175.0K | -$197.0K | $0.00 | -$103.0K | -$333.0K | |
| Accrued Liabilities Current | $6.4M | $8.4M | $3.8M | $1.9M | $3.2M | $6.7M | |
| Accounts Payable Current | $672.0K | $1.0M | $4.4M | $2.8M | $4.7M | $5.6M | |
| Contract With Customer Liability Current | $0.00 | $1.2M | $694.0K | $1.4M | $2.3M | $3.9M | |
| Warrant Liability Current | $11.0K | $0.00 | $114.0K | $10.7M | |||
| Temporary Equity Carrying Amount Attributable To Parent | |||||||
| Other Assets Noncurrent | $106.0K | $0.00 | |||||
| Investments | $723.0K | $822.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $624.0K | $88.0K | ||||
| Equity Method Investment Dividends Or Distributions | $0.00 | $3.0K | $106.0K | ||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $3.0K | -$105.0K | -$4.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.8M | $1.8M | $8.9M | -$19.0M | -$1.7M | $4.9M | $13.3M | $23.6M | -$109.9M | -$95.7M | -$88.6M | -$81.4M | $64.5M | $77.2M | $92.4M | -$63.2M | -$49.1M | -$30.7M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $21.3M | $22.8M | $19.7M | $28.0M | $4.5M | $13.2M | $17.2M | $22.4M | $10.3M | $4.6M | $1.2M | $73.0M | $102.7M | $117.3M | $130.5M | $14.1M | $5.0M | $987.0K | |||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $604.0K | -$23.0K | $0.00 | $0.00 | $0.00 | $0.00 | $905.0K | $0.00 | $0.00 | |||||||||
| Cash And Cash Equivalents At Carrying Value | $20.6M | $22.1M | $18.4M | $26.0M | $3.4M | $11.9M | $14.8M | $21.7M | $8.6M | $1.8M | $598.0K | $73.0M | $102.7M | $117.3M | $130.5M | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $225.0K | $208.0K | $0.00 | $196.0K | $149.0K | $144.0K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $240.0K | -$1.1M | $1.9M | -$15.8M | $95.8M | -$4.6M | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$226.0M | -$215.9M | -$205.3M | -$180.1M | -$161.3M | -$154.0M | -$133.3M | -$122.6M | -$258.5M | -$247.5M | -$238.5M | -$229.4M | -$230.0M | -$214.3M | -$197.2M | ||||||
| Property Plant And Equipment Net | $328.0K | $377.0K | $430.0K | $523.0K | $597.0K | $635.0K | $772.0K | $919.0K | $0.00 | $304.0K | $388.0K | $419.0K | $475.0K | $412.0K | $246.0K | ||||||
| Prepaid Expense And Other Assets Current | $854.0K | $510.0K | $1.9M | $3.3M | $2.9M | $1.6M | $3.4M | $4.5M | $1.7M | $1.5M | $2.5M | $3.2M | $1.7M | $2.4M | $3.0M | ||||||
| Operating Lease Right Of Use Asset | $5.0M | $5.3M | $5.5M | $5.9M | $6.1M | $6.4M | $6.8M | $7.0M | $126.0K | $3.4M | $3.6M | $3.8M | $4.2M | $4.4M | $4.5M | ||||||
| Operating Lease Liability Noncurrent | $4.4M | $4.6M | $4.9M | $5.3M | $5.6M | $5.8M | $6.2M | $6.4M | $70.0K | $2.7M | $3.0M | $3.2M | $3.7M | $3.9M | $4.2M | ||||||
| Operating Lease Liability Current | $981.0K | $952.0K | $926.0K | $877.0K | $854.0K | $881.0K | $938.0K | $985.0K | $227.0K | $968.0K | $943.0K | $918.0K | $870.0K | $847.0K | $780.0K | ||||||
| Liabilities Current | $6.5M | $9.9M | $11.4M | $9.0M | $7.6M | $6.0M | $11.5M | $7.6M | $2.0M | $8.2M | $7.8M | $10.4M | $17.9M | $20.5M | $17.0M | ||||||
| Liabilities And Stockholders Equity | $28.3M | $29.5M | $28.1M | $38.4M | $15.8M | $24.5M | $31.0M | $37.6M | $41.8M | $61.3M | $70.8M | $81.3M | $109.9M | $125.4M | $139.2M | ||||||
| Liabilities | $24.5M | $27.7M | $19.2M | $57.4M | $17.4M | $19.6M | $17.7M | $14.1M | $2.1M | $11.1M | $11.1M | $14.1M | $45.4M | $48.2M | $46.8M | ||||||
| Common Stock Value | $173.0K | $163.0K | $160.0K | $108.0K | $103.0K | $102.0K | $84.0K | $84.0K | $301.0K | $301.0K | $301.0K | $300.0K | $304.0K | $303.0K | $300.0K | ||||||
| Assets Current | $21.5M | $22.6M | $20.9M | $30.6M | $6.7M | $14.1M | $19.9M | $26.2M | $40.6M | $56.7M | $65.9M | $76.2M | $104.4M | $119.7M | $133.5M | ||||||
| Assets | $28.3M | $29.5M | $28.1M | $38.4M | $15.8M | $24.5M | $31.0M | $37.6M | $41.8M | $61.3M | $70.8M | $81.3M | $109.9M | $125.4M | $139.2M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$31.0K | -$70.0K | -$144.0K | -$202.0K | -$238.0K | -$270.0K | -$25.0K | -$2.0K | $165.0K | $302.0K | $98.0K | -$199.0K | -$73.0K | -$219.0K | -$287.0K | ||||||
| Accrued Liabilities Current | $5.2M | $5.1M | $5.8M | $4.9M | $5.3M | $3.3M | $4.4M | $2.3M | $1.1M | $4.9M | $4.1M | $5.2M | $5.3M | $4.7M | $4.1M | ||||||
| Accounts Payable Current | $321.0K | $3.9M | $4.0M | $2.0M | $1.1M | $1.1M | $4.4M | $4.3M | $692.0K | $2.2M | $2.7M | $3.4M | $7.7M | $9.3M | $6.7M | ||||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $680.0K | $1.3M | $350.0K | $627.0K | $1.7M | $0.00 | $0.00 | $0.00 | $653.0K | $3.7M | $5.2M | $3.8M | |||||||
| Warrant Liability Current | $26.0K | $32.0K | $9.0K | $24.0K | $33.0K | $75.0K | $386.0K | $514.0K | $714.0K | ||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $111.1M | $111.1M | $80.4M | $71.6M | $70.4M | $70.4M | |||||||||
| Other Assets Noncurrent | $864.0K | $61.0K | $75.0K | $86.0K | $78.0K | $33.0K | $38.0K | $38.0K | |||||||||||||
| Investments | $150.0K | $874.0K | $874.0K | $865.0K | $732.0K | $862.0K | $843.0K | $877.0K | |||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $618.0K | $525.0K | ||||||||||||||||||
| Equity Method Investment Dividends Or Distributions | $0.00 | $12.0K | $0.00 | ||||||||||||||||||
| Gain Loss On Sale Of Property Plant Equipment | $0.00 | $3.0K | -$105.0K | $0.00 | $0.00 | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $2.7M | $1.5M | $1.2M | $579.0K | $12.0M | $4.7M |
| Net Cash Provided By Used In Operating Activities | -$37.0M | -$37.1M | -$32.7M | -$22.2M | -$52.6M | -$22.9M |
| Net Cash Provided By Used In Investing Activities | -$16.0K | -$84.0K | -$32.0K | -$654.0K | -$382.0K | -$41.0K |
| Net Cash Provided By Used In Financing Activities | $36.7M | $42.3M | $38.6M | $21.2M | $107.2M | $52.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.1M | -$835.0K | $729.0K | $2.0M | -$4.0M | $2.0M |
| Increase Decrease In Other Noncurrent Assets | $170.0K | -$2.2M | $0.00 | -$114.0K | $106.0K | $0.00 |
| Increase Decrease In Operating Lease Liability | -$901.0K | -$911.0K | -$825.0K | -$535.0K | -$713.0K | -$560.0K |
| Increase Decrease In Contract With Customer Liability | -$1.2M | $475.0K | -$742.0K | $1.4M | -$27.5M | $29.8M |
| Increase Decrease In Accounts Payable | -$366.0K | -$3.3M | $23.0K | $1.1M | -$866.0K | -$5.6M |
| Proceeds From Stock Options Exercised | $149.0K | $39.0K | $127.0K | $82.0K | $980.0K | $47.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $48.0K | $22.0K | $0.00 | $0.00 | $3.0K | -$444.0K |
| Payments To Acquire Property Plant And Equipment | $16.0K | $87.0K | $66.0K | $654.0K | $382.0K | $41.0K |
| Proceeds From Issuance Of Common Stock | $16.2M | $4.6M | $7.0M | $0.00 | $107.5M | -$522.0K |
| Proceeds From Warrant Exercises | $1.3M | $0.00 | $0.00 | $861.0K | $751.0K | |
| Increase Decrease In Accrued Liabilities | -$2.0M | $4.7M | -$646.0K | $11.0K | $3.7M | |
| Proceeds From Notes Payable | $9.9M | $0.00 | $10.0M | $0.00 | $0.00 | $31.2M |
| Increase Decrease In Grant Receivables | -$806.0K | $806.0K | -$440.0K | |||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $2.5M | $36.0K | |||
| Adjustments Related To Tax Withholding For Share Based Compensation | $150.0K | $2.5M | $36.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 | Q1 2023 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $517.0K | $324.0K | $224.0K | $31.0K | $5.1M | $832.0K | |||
| Net Cash Provided By Used In Operating Activities | -$10.1M | -$12.1M | -$8.1M | -$15.7M | -$12.6M | -$8.7M | |||
| Net Cash Provided By Used In Investing Activities | $0.00 | $3.0K | -$17.0K | $0.00 | -$41.0K | -$20.0K | |||
| Net Cash Provided By Used In Financing Activities | $10.3M | $11.0M | $10.0M | -$14.0K | $108.4M | $3.9M | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $4.0K | -$1.1M | $1.2M | $1.5M | -$2.7M | $366.0K | |||
| Increase Decrease In Other Noncurrent Assets | $0.00 | -$160.0K | -$197.0K | -$28.0K | $38.0K | $0.00 | |||
| Increase Decrease In Operating Lease Liability | -$215.0K | -$244.0K | -$163.0K | -$215.0K | -$146.0K | -$152.0K | |||
| Increase Decrease In Contract With Customer Liability | -$489.0K | -$67.0K | -$507.0K | -$1.6M | -$371.0K | $0.00 | |||
| Increase Decrease In Accounts Payable | $3.0M | -$3.3M | $1.4M | -$1.3M | $1.1M | $1.4M | |||
| Proceeds From Stock Options Exercised | $7.0K | $0.00 | $40.0K | $0.00 | $1.0K | $1.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $31.0K | $0.00 | $79.0K | -$87.0K | -$3.0K | $233.0K | |||
| Payments To Acquire Property Plant And Equipment | $0.00 | $17.0K | $0.00 | $41.0K | $20.0K | ||||
| Proceeds From Issuance Of Common Stock | $835.0K | $5.1M | $0.00 | $0.00 | $110.6M | $0.00 | |||
| Proceeds From Warrant Exercises | $0.00 | $680.0K | $0.00 | ||||||
| Increase Decrease In Accrued Liabilities | -$1.1M | $2.0M | -$769.0K | $1.8M | |||||
| Proceeds From Notes Payable | $343.0K | $0.00 | $10.0M | $0.00 | $3.1M | ||||
| Increase Decrease In Grant Receivables | $0.00 | -$806.0K | $0.00 | $140.0K | |||||
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $1.1M | $0.00 | ||||||
| Adjustments Related To Tax Withholding For Share Based Compensation | $150.0K | $94.0K | $1.2M | $1.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 15.3M | 12.2M | 5.1M | 316.0K | 28.2M | 14.8M |
| Weighted Average Number Of Shares Outstanding Basic | 15.3M | 12.2M | 5.1M | 316.0K | 28.2M | 14.8M |
| Earnings Per Share Diluted | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 |
| Earnings Per Share Basic | $-2.58 | $-4.25 | $-6.96 | $-89.27 | $-1.93 | $-5.43 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 30.0M |
| Common Stock Shares Outstanding | 17.8M | 11.0M | 9.6M | 320.3K | 30.0M | 15.3M |
| Common Stock Shares Issued | 17.8M | 11.0M | 9.6M | 320.3K | 30.0M | 15.6M |
| Temporary Equity Shares Outstanding |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 16.7M | 16.1M | 13.0M | 13.6M | 11.3M | 10.3M | 8.4M | 2.9M | 324.1K | 317.5K | 314.6K | 30.0M | 29.8M | 29.7M | 23.4M | 14.8M | 14.5M | 14.5M | |||
| Weighted Average Number Of Shares Outstanding Basic | 16.7M | 16.1M | 13.0M | 13.6M | 11.3M | 10.3M | 8.4M | 2.9M | 324.1K | 317.5K | 314.6K | 30.0M | 29.8M | 29.7M | 23.4M | 14.8M | 14.5M | 14.5M | |||
| Earnings Per Share Diluted | $-0.60 | $-0.66 | $-0.87 | $-1.39 | $-0.64 | $-1.15 | $-1.27 | $-2.61 | $-24.77 | $-22.67 | $-23.20 | $-0.48 | $-0.53 | $-0.58 | $-1.56 | $-1.19 | $-1.40 | $-0.91 | |||
| Earnings Per Share Basic | $-0.60 | $-0.66 | $-0.87 | $-1.39 | $-0.64 | $-1.15 | $-1.27 | $-2.61 | $-24.77 | $-22.67 | $-23.20 | $-0.48 | $-0.53 | $-0.58 | $-1.56 | $-1.19 | $-1.40 | $-0.91 | |||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | |||||||
| Common Stock Shares Outstanding | 17.3M | 16.3M | 16.0M | 10.8M | 10.3M | 10.2M | 8.4M | 8.4M | 30.1M | 30.1M | 30.1M | 30.0M | 29.9M | 29.8M | 29.7M | ||||||
| Common Stock Shares Issued | 17.3M | 16.3M | 16.0M | 10.8M | 10.3M | 10.2M | 8.4M | 8.4M | 30.1M | 30.1M | 30.1M | 30.0M | 30.4M | 30.3M | 30.1M | ||||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.0M | 5.0M | 2.2M | 1.5M | 1.4M | 1.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.7M | $1.5M | $1.2M | $579.0K | $12.0M | $4.7M |
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $151.0K | $204.0K | $0.00 | -$245.0K | $668.0K |
| Fair Value Adjustment Of Warrants | $1.9M | $3.9M | $2.0K | $0.00 | $2.9M | $4.9M |
| Costs And Expenses | $37.7M | $45.0M | $35.7M | $23.7M | $67.6M | $58.2M |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $25.0K | $67.0K | $13.0K | $18.0K | ||
| Depreciation | $204.0K | $321.0K | $382.0K | $390.0K | $91.0K | $98.0K |
| Stock Issued During Period Value Stock Options Exercised | $149.0K | $39.0K | $127.0K | $7.0K | $980.0K | $47.0K |
| Additional Paid In Capital | $235.4M | $183.0M | $153.8M | $4.9M | $296.4M | $72.1M |
| Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss | $0.00 | -$3.6M | -$264.0K | |||
| Fair Value Option Changes In Fair Value Gain Loss1 | $0.00 | -$7.5M | -$11.4M | |||
| Amortization Of Financing Costs | $300.0K | $0.00 | $1.9M | $7.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $698.0K | $710.0K | $517.0K | $314.0K | $350.0K | $324.0K | $339.0K | $279.0K | $224.0K | $110.0K | $113.0K | $157.0K | $2.2M | $2.7M | $5.1M | $1.6M | $1.1M | $832.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $0.00 | $0.00 | -$1.0K | -$9.0K | $153.0K | -$33.0K | -$9.0K | $0.00 | $0.00 | $0.00 | $111.0K | -$204.0K | -$22.0K | -$53.0K | $338.0K | -$239.0K | $245.0K |
| Fair Value Adjustment Of Warrants | $1.8M | $859.0K | $507.0K | $5.6M | -$3.6M | $1.3M | -$6.0K | $23.0K | $0.00 | $0.00 | $0.00 | -$39.0K | -$128.0K | -$200.0K | $3.5M | $513.0K | $456.0K | $292.0K |
| Costs And Expenses | $8.0M | $10.1M | $10.7M | $10.3M | $10.9M | $10.2M | $10.8M | $7.8M | $7.8M | $5.8M | $6.2M | $16.1M | $17.2M | $18.8M | $20.3M | $12.4M | $18.0M | $13.4M |
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $2.7M | $716.0K | $5.0K | $9.0K | $11.0K | $11.0K | $11.0K | $34.0K | $3.0K | $3.0K | $3.0K | $2.0K | $6.0K | $13.0K | ||||
| Depreciation | $100.0K | $100.0K | $53.0K | $0.00 | $100.0K | $82.0K | $0.00 | $110.0K | $100.0K | $32.0K | $23.0K | $23.0K | $6.0K | $47.0K | $47.0K | $27.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $88.0K | $50.0K | $7.0K | $21.0K | $13.0K | $60.0K | $40.0K | $4.0K | $3.0K | $1.0K | $786.0K | $79.0K | $1.0K | $37.0K | -$1.0K | |||
| Additional Paid In Capital | $229.8M | $217.8M | $214.3M | $161.4M | $159.9M | $159.2M | $146.6M | $146.2M | $297.7M | $297.1M | $297.9M | $296.5M | $298.5M | $295.6M | $292.7M | |||
| Financial Instruments Subject To Mandatory Redemption By Settlement Terms Change In Fair Value Gain Loss | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$3.6M | $10.0K | $0.00 | $0.00 | |||||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$7.5M | -$3.3M | -$1.9M | -$454.0K | |||||||||
| Amortization Of Financing Costs | $300.0K | $0.00 | $1.9M | $157.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.